WW International (NASDAQ: WW) executives outlined the company's efforts to reposition its weight-management business around behavioral support, telehealth and GLP-1 medications, following a restructuring that substantially reduced its debt burden. Speaking at Morgan Stanley's healthcare conference, Chief Financial Officer Felicia DellaFortuna said the company reduced debt from approximately $1.6 billion to about $465 million through its

